Steven Cohen’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Other funds holding FULC
Steven Cohen's FULC Position: Q3 2026 in Review
Steven Cohen increased its Fulcrum Therapeutics (FULC) stake by 41% in Q3 2026, buying an estimated $999K and bringing the position to 917,801 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2057.
Steven Cohen first reported a position in FULC in Q2 2020 and has held it in 18 quarters since. The position peaked at $27.1M in Q4 2025. 150 funds tracked by Wall St. Rank hold FULC as of Q3 2026.
- Steven Cohen held 917,801 shares of Fulcrum Therapeutics worth $3.4M as of Q3 2026.
- Steven Cohen bought 266,374 Fulcrum Therapeutics shares in Q3 2026, an estimated $999K.
- Fulcrum Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2057 holding.
- Steven Cohen first reported a position in Fulcrum Therapeutics in Q2 2020 and has held it in 18 quarters since.
- Steven Cohen's Fulcrum Therapeutics position peaked at $27.1M in Q4 2025.
- 150 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.